SCHEMBL5157936

SCHEMBL5157936

COc1ccc(-c2c(-c3cc(Cl)ccc3O)c3cccc(C(F)(F)F)c3[nH]c2=O)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.40
CAPN1 P07384 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP1A1 P04798 2/20 0.38
CYP1B1 Q16678 2/20 0.38
PGR P06401 1/20 0.38
GUSB P08236 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
GSK3B P49841 2/20 0.36
EEF2K O00418 1/20 0.36
PLK4 O00444 1/20 0.36
IKBKB O14920 1/20 0.36
DYRK3 O43781 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5159726 0.86 CYP2C9 (0.42) CYP2C9CAPN1CYP1A2CYP3A4CYP2D6
SCHEMBL5159454 0.84 CYP2C9 (0.43) CYP2C9CAPN1CYP1A2CYP1A1CYP1B1
SCHEMBL5160100 0.84 CAPN1 (0.41) CYP2C9CAPN1CYP1A2CYP3A4CYP2D6
SCHEMBL5157833 0.83 CYP2C9 (0.42) CYP2C9CAPN1PGRCA1CA2
SCHEMBL5157933 0.81 CYP2C9 (0.60) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5159401 0.80 CAPN1 (0.44) CYP2C9CAPN1CYP1A2CYP3A4CYP2D6
SCHEMBL5160619 0.80 TNKS (0.41) CYP2C9CAPN1PGRTNKSTNKS2
SCHEMBL5159768 0.80 CYP2C9 (0.42) CYP2C9CAPN1CYP1A2CYP3A4CYP2D6
SCHEMBL5162844 0.78 CYP2C9 (0.58) CYP2C9CAPN1CYP1A2CYP3A4CYP2D6
SCHEMBL7485354 0.78 CYP2C9 (0.48) CYP2C9CAPN1PGRTNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133474-B1 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2007-02-21 EP claimed